A carregar...
Report of ipilimumab in a heart transplant patient with metastatic melanoma on tacrolimus
Ipilimumab is the first immunotherapy shown to increase overall survival in patients with metastatic melanoma. Currently, there are no accepted guidelines for use of ipilimumab in organ transplant patients. There is only one report in the literature on successful administration of ipilimumab in two...
Na minha lista:
| Publicado no: | Melanoma Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096438/ https://ncbi.nlm.nih.gov/pubmed/30190859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt.15.27 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|